LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 92.98 | 84.90 | 994 | 7257 | 0.1370 | 0.4672 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 92.98 | 84.90 | 12919 | 7257 | 1.7801 | 1.1880 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 94.68 | 84.90 | 1 | 7000 | 0.0001 | -0.5023 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 94.68 | 84.90 | 3830 | 7000 | 0.5471 | 0.8192 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 94.68 | 84.90 | 1 | 7000 | 0.0001 | -0.5023 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 94.68 | 84.90 | 561 | 7000 | 0.0801 | 0.3453 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 94.68 | 84.90 | 871 | 7000 | 0.1244 | 0.4416 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 94.68 | 84.90 | 12649 | 7000 | 1.8069 | 1.1948 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 94.68 | 84.90 | 852 | 7000 | 0.1217 | 0.4366 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 94.68 | 84.90 | 13413 | 7000 | 1.9160 | 1.2151 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 2.66 | 84.90 | 585 | 285 | 2.0473 | 2.0113 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 2.66 | 84.90 | 4 | 285 | 0.0140 | -0.8253 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 2.66 | 84.90 | 470 | 285 | 1.6449 | 1.6575 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 4.36 | 84.90 | 3 | 322 | 0.0093 | -0.8237 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 4.36 | 84.90 | 664 | 322 | 2.0585 | 1.9096 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 4.36 | 84.90 | 9 | 322 | 0.0279 | -0.6882 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 4.36 | 84.90 | 585 | 322 | 1.8136 | 1.7244 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 6.06 | 84.90 | 5 | 365 | 0.0137 | -0.7394 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 6.06 | 84.90 | 747 | 365 | 2.0440 | 1.8085 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 6.06 | 84.90 | 6 | 365 | 0.0164 | -0.7158 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 6.06 | 84.90 | 669 | 365 | 1.8306 | 1.6652 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 7.77 | 84.90 | 5 | 411 | 0.0122 | -0.7118 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 7.77 | 84.90 | 836 | 411 | 2.0329 | 1.7315 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 7.77 | 84.90 | 9 | 411 | 0.0219 | -0.6269 | MN20160318_Q02 | E21 |